Responses
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016Authors' ReplyShow More
Dear Editor,
We would like to thank Drs Sony and Garg for their comments on our study [1]. As also pointed out in the study itself, we completely agree with Drs Sony and Garg that steroids, in this case, intravitreal triamcinolone acetonide, may have to be avoided in the treatment of central serous chorioretinopathy. The purpose of the study was to report on the negative experience we gained. The reason why we p...
Conflict of Interest:
None declared. - Published on: 22 March 2016Intravitreal triamcinolone acetonide and central serous chorioretinopathyShow More
Dear Editor,
We read with great interest the article by Jonas and Kamppeter on “Intravitreal triamcinolone acetonide and central serous chorioretinopathy” [1]. Intravitreal triamcinolone acetonide has been increasingly used for treatment of wide variety of macular edema. Central serous chorioretinopathy is a relatively common retinal disease, which has been shown to be more prevalent in patients with type-A beha...
Conflict of Interest:
None declared.